register

News & Trends - MedTech & Diagnostics

$8 million investment in world-class clinical trials

Health Industry Hub | October 8, 2019 |

Five Australian-led trials will receive funding from the Government’s Medical Research Future Fund International Clinical Trial Collaborations program.

Researchers at the University of Western Australia will receive $1.8 million to investigate the best approach for treating severe narrowing of the aortic heart valve (aortic stenosis), which is a very common condition. This large clinical trial will test if earlier valve replacement will improve outcomes for patients.

Macquarie University has received $3.1 million to investigate reducing the risk of dementia by protecting brain health through lifestyle changes.  

The George Institute for Global Health will receive $902,000 to evaluate the best treatments for aneurysmal subarachnoid haemorrhage caused by a burst artery in the brain. In people aged between 40 and 60 years with this condition, nearly half will die and a third will suffer permanent disability. The clinical trial will help doctors better manage patients with this condition.

The University of Newcastle will receive $782,000 to trial the use a new type of wound dressing on patients to reduce infections following emergency abdominal surgery. 

Fully connected clients are 52% more valuable.
Differentiate your organisation and amplify your brand value proposition to our 8,500+ industry professionals. Health Industry Hub offers a wealth of content in the only one-stop-hub to connect and engage Pharma, MedTech and Biotech industry professionals. Ask us how.

The Murdoch Children’s Research Institute will receive $1.4 million to investigate the best ways to support fragile lungs in preterm babies, which are prone to collapse and cause injury from the first time they breathe. While positive end-expiratory pressure (PEEP) at birth is essential to support the preterm lung, this project will conduct the first large clinical trial of PEEP strategies in preterm infants. This clinical trial will provide important guidance to clinicians across all health care settings worldwide.

Each project will run at least one clinical trial site in Australia with Australian patients, while collaborating with international researchers or trial teams.  

The International Clinical Trial Collaborations program supports Australian researchers, to collaborate globally to develop new or novel drug applications, devices and treatments. 

You may also like New Medicare subsidies for breast cancer scans


News & Trends - Pharmaceuticals

Federal court dismisses Arrotex dispute against Health Minister

Federal court dismisses Arrotex dispute against Health Minister

Health Industry Hub | July 12, 2024 |

Pharma News: The Federal Court has ruled against Arrotex Pharmaceuticals in their bid to challenge the Minister for Health and […]

More


News & Trends - Pharmaceuticals

Largest diabetes study reveals major benefits of dual therapy with SGLT2 inhibitors and GLP1 receptor agonists

Largest diabetes study reveals major benefits of SGLT2 inhibitors and GLP1 receptor agonists dual therapy

Health Industry Hub | July 12, 2024 |

Pharma News: Combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is likely to […]

More


News & Trends - Pharmaceuticals

Queensland opens first regional CAR T-cell treatment centre

Queensland launches first regional CAR T-cell treatment centre

Health Industry Hub | July 12, 2024 |

Pharma News: Gilead Sciences and Lymphoma Australia have welcomed the opening of Australia’s first regional CAR T-cell treatment centre at […]

More


News & Trends - Pharmaceuticals

Government inaction leaves essential medicine shortages unresolved

Government inaction leaves essential medicine shortages unresolved

Health Industry Hub | July 12, 2024 |

Pharma News: Over the past 12 months, at least six essential medications and products have been withdrawn from the Australian […]

More


This content is copyright protected. Please subscribe to gain access.